Vireo Growth Inc. SEC filings VREOF

Vireo Growth Inc. has 362 filings in SEC EDGAR's recent list, going back to Apr 1, 2019. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, agreement ended, new debt, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
10-K Annual report Mar 17, 2026 Dec 31, 2025
ARS Annual report to shareholders May 9, 2025 Dec 31, 2024
10-K Annual report Mar 4, 2025 Dec 31, 2024
ARS Annual report to shareholders May 10, 2024 Dec 31, 2023
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 29, 2022 Dec 31, 2021
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VREOF (OTC)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Minneapolis, MN
SEC filer status
, Emerging growth company
SEC CIK
1771706
Former names
Goodness Growth Holdings, Inc. (until Jun 24, 2024); Vireo Health International, Inc. (until May 14, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.